Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia ...

Paul Hudson, CEO of Sanofi, has been driving an all-encompassing effort to use AI to reshape the way the company ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Canaccord Genuity 45th Annual Growth ...

Questions to help you build a strong foundation of trust, alignment, and enthusiasm. Sign up for HBR Executive Agenda - for insights you need to steer your business now. Only available to HBR ...

Jeh Aerospace has raised $11 million in a Series A funding round led by Elevation Capital, with participation from existing ...

The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...

Biosimilars, once met with skepticism, are now an undeniable force in the global pharmaceutical market. As several ...

Useful and surprising findings from across academia, consultancies, and other vetted sources. Sign up for HBR Executive Agenda - for insights you need to steer your business now. Only available to HBR ...